CBD in Dominica: not individually verified

What Dominica HAS confirmed for related substances

These are related compounds, not CBD. Their status may or may not reflect CBD’s. Confirm CBD directly with Dominica's national drug authority or your embassy.

• Cannabis / THCa related compound, not CBD

  Cannabis is a Class B controlled drug under the Drugs (Prevention of Misuse) Act, Chapter 40:07. Part II of the Third Schedule prints the entry «Cannabis and cannabis resin». Plant and resin are printed as one Class B entry rather than two, while section 2 defines «cannabis» as any plant of the genus Cannabis or any part of it and «cannabis resin» as the separated resin; section 8 adds a separate offence of cultivating the cannabis plant, whose penalty sits in the Fourth Schedule's General column and not in the Class B column. Section 4(1)(a) makes a controlled drug any substance for the time being specified in Parts I, II or III of that Schedule and section 4(1)(b) makes a Class B drug any substance specified in Part II. Paragraph 3 of Part II extends the entry to any salt of the listed substance and paragraph 4 to any preparation or other product containing it. The placement is stated as at the revision this text carries: the Third Schedule occupies printed pages 30 to 33 and those pages are authorised by the footer note «L.R.O. 1/1991». Section 4(3) lets the Minister amend Parts I to III by Order after consulting the Advisory Council, and this consolidation reproduces no Order made after that authorisation, so the placement stated here is a floor and not a closed account of the position today. The compilation recorded «CANNABIS» as the printed entry for this row. The Act does carry that word, but not in that form and not on its own: it is a recased fragment of a longer printed entry, and the entry quoted above is what the page actually prints. The rest of that record's quotation column is largely in another language and nothing else from it was carried across. This is the one row in this batch where a later amendment was found, read in full and applied, and it changes the practical answer rather than the placement. The Drugs (Prevention of Misuse) (Amendment) Act 2020, Act No. 16 of 2020, gazetted 30 October 2020, leaves the Third Schedule untouched, so cannabis and cannabis resin remain a Class B entry, but it inserts a new section 7A whose subsection (2) provides that a person who has twenty-eight grammes or less of cannabis or cannabis resin in his possession is not guilty of an offence under section 7(2), while subsection (1) makes it unlawful to have more than that amount. Its subsection (3) treats a conviction before a relevant date for possession of twenty-eight grammes or less as spent, subsection (4) leaves that date to be prescribed by the Minister by Order, and subsection (5) withholds the spent conviction rule from a person under eighteen. So possession at or below the threshold is decriminalised and possession above it is not, and the compilation read alongside the Act was right about this while the consolidation held in this repository predates it by nearly thirty years.

  Dominica, the Drugs (Prevention of Misuse) Act, Act 20 of 1988 as amended by Act 15 of 1989 and Act 15 of 1990, revised edition Chapter 40:07, sections 4, 5, 6, 7, 27, 29 and 32 and the Third and Fourth Schedules · read from the 64 page scanned chapter held in this repository at research/instruments/dominica/dm-drugs-prevention-of-misuse-1988.pdf, sha256 30ca6c954678725f8bd4ea81de7b081e5b3ef5ef9015d05e357de1992c62ab30, with its text layer at dm-drugs-prevention-of-misuse-1988.txt, sha256 d47a9b795cabe1a1250ebd6ec3e13e4ccb6367708b69fded78a8eb22b7ab1465. The entry relied on for this row is «Cannabis and cannabis resin» in Part II, read on printed page 32 as a page image rendered from the scan, because the text layer of this scan silently drops the «Part II» and «Part III» headings and one numbered paragraph in each of those Parts · the complete Class A, Class B and Class C lists were read that way and not by searching the text. The Third Schedule pages carry the footer «L.R.O. 1/1991» and the Fourth Schedule figures quoted here were read off the page images of printed pages 34 and 35. This citation is document level and not per substance: the compilation's links column for this row holds the constructed text «cannabis national source» rather than an address, and no per row source exists. The compilation recorded «CANNABIS» as the printed entry for this row. The Act does carry that word, but not in that form and not on its own: it is a recased fragment of a longer printed entry, and the entry quoted above is what the page actually prints. The rest of that record's quotation column is largely in another language and nothing else from it was carried across. The Part and Class placement stated for this row is not printed in the quotation column of the compilation read alongside the Act: measured across that compilation, not one of its 88 rows carries a Part, a Class or a Schedule marker of any kind, and its instrument column says only that there is a controlled-drug schedule without naming which of the four Schedules that is. Every division named in this cell is therefore taken from the printed Third Schedule pages of the Act itself. Second instrument relied on: Dominica, the Drugs (Prevention of Misuse) (Amendment) Act 2020, Act No. 16 of 2020, assented to and gazetted 30 October 2020 and passed in the House of Assembly on 26 October 2020, a four page Act read in full from the Government of Dominica laws site at https://dominica.gov.dm/laws/2020/Drug%20Prevention%20(Amendment)%20Act%202020.pdf, sha256 c5f6a5b47cee1ffce3f88993d72163a1f0ba6a1f3cf68c31f8bfed89e1c5af01. It amends section 7(4), inserts sections 7A and 7B, amends section 8 and makes no amendment to the Third Schedule. Read as at 22 September 2026. · Verified September 21, 2026

• Delta-8-THCa related compound, not CBD

  Delta-8-THC is controlled in Dominica by derivation, and material still inside the plant is controlled instead under the Class B cannabis entry. It is reached by the Third Schedule to the Drugs (Prevention of Misuse) Act, Chapter 40:07, from a printed entry rather than by a printed entry of its own. Delta-8-THC is not printed by name. Part I prints «Cannabinol derivatives» as an entry and Part IV defines that expression as tetrahydro derivatives of cannabinol and 3-alkyl homologues of cannabinol or of its tetrahydro derivatives, except where contained in cannabis or cannabis resin. Delta-8-tetrahydrocannabinol is a tetrahydro derivative of cannabinol, which is the first of the two limbs the definition names, so it is reached in one step. That is a derivation resting on the Part IV definition and not a printed entry. Section 4(1)(a) makes a controlled drug any substance for the time being specified in Parts I, II or III of that Schedule and section 4(1)(b) makes a Class A drug any substance specified in Part I. Paragraph 4 of Part I extends the entry to any salt of the listed substance and paragraph 5 to any preparation or other product containing it. The placement is stated as at the revision this text carries: the Third Schedule occupies printed pages 30 to 33 and those pages are authorised by the footer note «L.R.O. 1/1991». Section 4(3) lets the Minister amend Parts I to III by Order after consulting the Advisory Council, and this consolidation reproduces no Order made after that authorisation, so the placement stated here is a floor and not a closed account of the position today.

  Dominica, the Drugs (Prevention of Misuse) Act, Act 20 of 1988 as amended by Act 15 of 1989 and Act 15 of 1990, revised edition Chapter 40:07, sections 4, 5, 6, 7, 27, 29 and 32 and the Third and Fourth Schedules · read from the 64 page scanned chapter held in this repository at research/instruments/dominica/dm-drugs-prevention-of-misuse-1988.pdf, sha256 30ca6c954678725f8bd4ea81de7b081e5b3ef5ef9015d05e357de1992c62ab30, with its text layer at dm-drugs-prevention-of-misuse-1988.txt, sha256 d47a9b795cabe1a1250ebd6ec3e13e4ccb6367708b69fded78a8eb22b7ab1465. The entry relied on for this row is «Cannabinol derivatives» in Part I, read on printed page 30 or 31 as a page image rendered from the scan, because the text layer of this scan silently drops the «Part II» and «Part III» headings and one numbered paragraph in each of those Parts · the complete Class A, Class B and Class C lists were read that way and not by searching the text. The Third Schedule pages carry the footer «L.R.O. 1/1991» and the Fourth Schedule figures quoted here were read off the page images of printed pages 34 and 35. This citation is document level and not per substance: the compilation's links column for this row holds the constructed text «delta-8-thc national source» rather than an address, and no per row source exists. The compilation read for this row recorded no printed entry claim, so nothing from it was carried across. The Part and Class placement stated for this row is not printed in the quotation column of the compilation read alongside the Act: measured across that compilation, not one of its 88 rows carries a Part, a Class or a Schedule marker of any kind, and its instrument column says only that there is a controlled-drug schedule without naming which of the four Schedules that is. Every division named in this cell is therefore taken from the printed Third Schedule pages of the Act itself. Second instrument relied on: Dominica, the Drugs (Prevention of Misuse) (Amendment) Act 2020, Act No. 16 of 2020, assented to and gazetted 30 October 2020 and passed in the House of Assembly on 26 October 2020, a four page Act read in full from the Government of Dominica laws site at https://dominica.gov.dm/laws/2020/Drug%20Prevention%20(Amendment)%20Act%202020.pdf, sha256 c5f6a5b47cee1ffce3f88993d72163a1f0ba6a1f3cf68c31f8bfed89e1c5af01. It amends section 7(4), inserts sections 7A and 7B, amends section 8 and makes no amendment to the Third Schedule. Read as at 22 September 2026. · Verified October 8, 2026

• Synthetic Cannabinoids (K2 / Spice)a related compound, not CBD

  Synthetic cannabinoids is a market label covering many chemically distinct compounds, and the Act reaches a compound only through a printed entry or a printed definition. The only definition that could bear on the label is Part IV's, which defines «cannabinol derivatives» as tetrahydro derivatives of cannabinol and 3-alkyl homologues of cannabinol or of its tetrahydro derivatives. That is a closed description of the cannabinol skeleton. The indazole and indole carboxamides sold under this label are not built on that skeleton and are not reached by it, and no generic clause covering compounds by receptor activity appears anywhere in Parts I to III. So the label is answered compound by compound, and for the carboxamide families the answer from this instrument is that nothing places them. The compilation recorded «CANNABINOIDES SINTÉTICOS» as the printed entry for this row. That string does not appear anywhere in this Act; the Act is written in English and that record's quotation column is largely in another language, which is a property of the record rather than of the instrument, so it is reported here and is not offered as a quotation from the Act. The reading is stated as at the revision note «L.R.O. 1/1991» printed in the footer of those pages; section 4(3) lets the Minister amend Parts I to III by Order and this consolidation reproduces none made after that note.

  Dominica, the Drugs (Prevention of Misuse) Act, Act 20 of 1988 as amended by Act 15 of 1989 and Act 15 of 1990, revised edition Chapter 40:07, sections 4, 7, 27 and 29 and the Third and Fourth Schedules · read from the 64 page scanned chapter held in this repository at research/instruments/dominica/dm-drugs-prevention-of-misuse-1988.pdf, sha256 30ca6c954678725f8bd4ea81de7b081e5b3ef5ef9015d05e357de1992c62ab30, with its text layer at dm-drugs-prevention-of-misuse-1988.txt, sha256 d47a9b795cabe1a1250ebd6ec3e13e4ccb6367708b69fded78a8eb22b7ab1465. The complete Part I, Part II and Part III lists on printed pages 30, 31 and 32 were read as page images rendered from the scan and not by searching the text layer, which drops the «Part II» and «Part III» headings and one numbered paragraph in each of those Parts. Those pages carry the footer «L.R.O. 1/1991». This citation is document level and not per substance: the compilation's links column for this row holds the constructed text «synthetic-cannabinoids national source» rather than an address. The compilation recorded «CANNABINOIDES SINTÉTICOS» as the printed entry for this row. That string does not appear anywhere in this Act · the Act is written in English and that record's quotation column is largely in another language, which is a property of the record rather than of the instrument, so it is reported here and is not offered as a quotation from the Act. The Part and Class placement stated for this row is not printed in the quotation column of the compilation read alongside the Act: measured across that compilation, not one of its 88 rows carries a Part, a Class or a Schedule marker of any kind, and its instrument column says only that there is a controlled-drug schedule without naming which of the four Schedules that is. Every division named in this cell is therefore taken from the printed Third Schedule pages of the Act itself. Second instrument relied on: Dominica, the Drugs (Prevention of Misuse) (Amendment) Act 2020, Act No. 16 of 2020, assented to and gazetted 30 October 2020 and passed in the House of Assembly on 26 October 2020, a four page Act read in full from the Government of Dominica laws site at https://dominica.gov.dm/laws/2020/Drug%20Prevention%20(Amendment)%20Act%202020.pdf, sha256 c5f6a5b47cee1ffce3f88993d72163a1f0ba6a1f3cf68c31f8bfed89e1c5af01. It amends section 7(4), inserts sections 7A and 7B, amends section 8 and makes no amendment to the Third Schedule. Read as at 22 September 2026. · Verified September 21, 2026

• THC-Pa related compound, not CBD

  THC-P is a Class A controlled drug under the Drugs (Prevention of Misuse) Act, Chapter 40:07, reached by derivation from a printed definition rather than by a printed entry of its own. THC-P is not printed by name. Part I of the Third Schedule prints «Cannabinol derivatives» as an entry, and Part IV, on printed page 33, defines that expression as «the following substances, except where contained in cannabis or cannabis resin, namely tetrahydro derivatives of cannabinol and 3-alkyl homologues of cannabinol or of its tetrahydro derivatives». THC-P, delta-9-tetrahydrocannabiphorol, is PubChem CID 6453074, named «(6aR,10aR)-3-heptyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol», and delta-9-THC is CID 16078, named «(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol». The two share the tetrahydro skeleton and differ only in the alkyl group at the 3-position, a heptyl in place of a pentyl, so THC-P is a 3-alkyl homologue of a tetrahydro derivative of cannabinol, which is what the second limb names. That is one step and not two. This row was previously left open on the reading that reaching it took two steps the definition did not say could be combined, and that the Act supplies no range of chain lengths. The second limb names homologues of the tetrahydro derivatives in terms, so no combination is needed, and the definition sets no limit on the alkyl group, so a heptyl is within it on the face of the words. The same chemical premise is imported here as in the delta-8-THC row, and it is a premise about the compound and not something the Act states. The Advisory Council on the Misuse of Drugs in the United Kingdom, construing the identical words in the UK Misuse of Drugs Act 1971, reported in 2025 that variants of THC «where the side-chain is a different alkyl chain (e.g. THCH, THCP)» are «all covered by the current UK generic control». That is a UK body reading the same words and is persuasive only, not Dominican authority, and in the UK those words sit in Class B, while Dominica prints «Cannabinol derivatives» in Part I, which is Class A. The exception means THC-P occurring naturally inside cannabis plant material or resin answers to the Class B cannabis entry instead. The Act does not settle the common retail form, hemp flower sprayed with THC-P made outside the plant: section 2 defines «cannabis» as «any plant of the genus Cannabis or any part of any such plant» with no potency figure, so the flower itself is Class B, and whether added THC-P on it is «contained in cannabis» within the exception or is a separate Class A product under paragraph 5 of Part I is not answered by the printed words. Section 4(1)(a) makes a controlled drug any substance for the time being specified in Parts I, II or III of that Schedule, section 4(1)(b) makes a Class A drug any substance specified in Part I, and section 4(2) gives Part IV effect for the meanings of expressions used in the Schedule. Paragraph 4 of Part I extends the entry to any salt of the listed substance and paragraph 5 to any preparation or other product containing it. The placement is stated as at the revision this text carries: the Third Schedule occupies printed pages 30 to 33 and those pages are authorised by the footer note «L.R.O. 1/1991». Section 4(3) lets the Minister amend Parts I to III by Order after consulting the Advisory Council, and this consolidation reproduces no Order made after that authorisation, so the placement stated here is a floor and not a closed account of the position today. The Government of Dominica laws site itself was still serving this chapter on 24 April 2025, and the Internet Archive capture of that day is byte-identical to the copy read, so no reconsolidation of the chapter had been published by then; an Order under section 4(3) would not appear in that file either way.

  Dominica, the Drugs (Prevention of Misuse) Act, Act 20 of 1988 as amended by Act 15 of 1989 and Act 15 of 1990, revised edition Chapter 40:07, sections 2, 4, 5, 6, 7, 16, 17, 27, 28, 29, 30 and 32, the Third Schedule Parts I and IV and the Fourth Schedule, and the Drugs (Prevention of Misuse) Regulations, regulations 4, 5, 6, 7, 9, 14 and 15 and their Fourth Schedule on printed page 59, with sections 8, 11, 13, 14 and 15 of the Act for the General column and the practitioner directions · read from the 64 page scanned chapter held in this repository at research/instruments/dominica/dm-drugs-prevention-of-misuse-1988.pdf, sha256 30ca6c954678725f8bd4ea81de7b081e5b3ef5ef9015d05e357de1992c62ab30, with its text layer at dm-drugs-prevention-of-misuse-1988.txt, sha256 d47a9b795cabe1a1250ebd6ec3e13e4ccb6367708b69fded78a8eb22b7ab1465. The Part I entry «Cannabinol derivatives» was read on printed page 30 and the Part IV definition on printed page 33, as page images and not by searching the text, and the Fourth Schedule figures were read off the page images of printed pages 34 to 38. The same file, sha256 30ca6c954678725f8bd4ea81de7b081e5b3ef5ef9015d05e357de1992c62ab30, is what the Government of Dominica laws site served on 24 April 2025, read through the Internet Archive capture at https://web.archive.org/web/20250424200632/http://dominica.gov.dm/laws/chapters/chap40-07.pdf because on 3 October 2026 dominica.gov.dm did not resolve in DNS to curl, to Python urllib or to WebFetch. This citation is document level and not per substance: the compilation's links column for this row holds the constructed text «thc-p national source» rather than an address. The compilation read for this row recorded no printed entry claim, so nothing from it was carried across. The Part and Class placement stated for this row is not printed in the quotation column of the compilation read alongside the Act: measured across that compilation, not one of its 88 rows carries a Part, a Class or a Schedule marker of any kind, and its instrument column says only that there is a controlled-drug schedule without naming which of the four Schedules that is. Every division named in this cell is therefore taken from the printed Third Schedule pages of the Act itself. Second instrument relied on: Dominica, the Drugs (Prevention of Misuse) (Amendment) Act 2020, Act No. 16 of 2020, assented to and gazetted 30 October 2020 and passed in the House of Assembly on 26 October 2020, a four page Act read in full, originally published at https://dominica.gov.dm/laws/2020/Drug%20Prevention%20(Amendment)%20Act%202020.pdf and read on 3 October 2026 through the Internet Archive capture at https://web.archive.org/web/20251022235219/https://dominica.gov.dm/laws/2020/Drug%20Prevention%20(Amendment)%20Act%202020.pdf, sha256 c5f6a5b47cee1ffce3f88993d72163a1f0ba6a1f3cf68c31f8bfed89e1c5af01. It amends section 7(4), inserts sections 7A and 7B, amends section 8 and makes no amendment to the Third Schedule. Chemical identity: PubChem compound records CID 6453074, tetrahydrocannabiphorol, and CID 16078, dronabinol, read through the PubChem PUG REST service at https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/tetrahydrocannabiphorol/property/IUPACName,MolecularFormula/JSON and https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/dronabinol/property/IUPACName,MolecularFormula/JSON. Persuasive reading of the identical definition: Advisory Council on the Misuse of Drugs, «'Semi-synthetic' Cannabinoids: Cannabinoids related to tetrahydro-cannabinol and cannabidiol», 2025, paragraph 3.11 and the annex on broadening the UK generic, at https://assets.publishing.service.gov.uk/media/682f3f03c054883884bff465/ACMD+Report+-+Semi-synthetic+Cannabinoids+Cannabinoids+related+to+tetrahydro-cannabinol+and+cannabidiol+redacted+FINAL2.pdf, sha256 f343579f9678e8f01d99c01e1f7c6bd453dbbff7bee8739338bb101777694e14. Read as at 3 October 2026. · Verified October 3, 2026